1	Earn	earn	VBP	pb=earn.01	0	root	_
2	Free	free	NNP	_	3	nn	_
3	CME	cme	NNP	_	4	nn	_
4	Credits	credits	NNP	p2=NNPS	1	dobj	1:A1=PPT
5	by	by	IN	_	1	prep	1:AM-MNR
6	reading	read	VBG	pb=read.01	5	pcomp	_
7	the	the	DT	_	10	det	_
8	latest	late	JJS	_	10	amod	_
9	medical	medical	JJ	_	10	amod	_
10	news	news	NN	_	6	dobj	6:A1=PPT
11	in	in	IN	_	10	prep	_
12	your	your	PRP$	_	13	poss	_
13	specialty	specialty	NN	_	11	pobj	_
14	.	.	.	_	1	punct	_

1	For	for	IN	_	5	prep	5:AM-PRP
2	best	good	JJS	p2=RBS	3	amod	_
3	viewing	viewing	NN	p2=VBG	1	pobj	_
4	,	,	,	_	5	punct	_
5	click	click	VB	pb=click.01	0	root	_
6	the	the	DT	_	9	det	_
7	bottom	bottom	JJ	p2=NN	9	amod	_
8	right	right	JJ	_	9	amod	_
9	corner	corner	NN	_	5	dobj	5:A1=PPT
10	for	for	IN	_	9	prep	_
11	full	full	JJ	_	12	amod	_
12	screen	screen	NN	_	10	pobj	_
13	.	.	.	_	5	punct	_

1	Treatment	treatment	NN	p2=NNP	0	root	_
2	of	of	IN	_	1	prep	_
3	patients	patient	NNS	_	2	pobj	_
4	with	with	IN	_	3	prep	_
5	idiopathic	idiopathic	JJ	_	7	amod	_
6	pulmonary	pulmonary	JJ	_	7	amod	_
7	fibrosis	fibrosis	NN	p2=NNS	4	pobj	_
8	for	for	IN	_	1	prep	_
9	52	0	CD	_	10	num	_
10	weeks	week	NNS	_	8	pobj	_
11	with	with	IN	_	1	prep	_
12	pirfenidone	pirfenidone	NN	_	11	pobj	_
13	,	,	,	_	12	punct	_
14	an	an	DT	_	19	det	_
15	antifibrotic	antifibrotic	JJ	p2=NN	19	amod	_
16	,	,	,	_	19	punct	_
17	reduced	reduce	VBN	p2=JJ|pb=reduce.01	19	amod	_
18	disease	disease	NN	_	19	nn	_
19	progression	progression	NN	_	12	appos	17:A1=PPT
20	.	.	.	_	1	punct	_

1	All	all	DT	p2=RB	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	cause	cause	NN	_	4	nn	_
4	mortality	mortality	NN	_	7	nsubjpass	7:A1=PPT
5	was	be	VBD	_	7	auxpass	_
6	significantly	significantly	RB	_	7	advmod	7:AM-MNR
7	reduced	reduce	VBN	pb=reduce.01	0	root	_
8	in	in	IN	_	7	prep	7:AM-LOC
9	patients	patient	NNS	_	8	pobj	10:A0=PAG
10	receiving	receive	VBG	pb=receive.01	9	partmod	_
11	the	the	DT	_	12	det	_
12	drug	drug	NN	_	10	dobj	10:A1=PPT
13	in	in	IN	_	10	prep	10:AM-LOC
14	a	a	DT	_	16	det	_
15	pooled	pool	VBN	p2=JJ|pb=pool.01	16	amod	_
16	analysis	analysis	NN	_	13	pobj	15:A1=PPT
17	with	with	IN	_	16	prep	_
18	prior	prior	JJ	_	19	amod	_
19	studies	study	NNS	_	17	pobj	_
20	.	.	.	_	7	punct	_

1	SAN	san	NNP	p2=NN	2	nn	_
2	DIEGO	diego	NNP	_	12	nsubj	_
3	--	--	:	_	2	punct	_
4	The	the	DT	_	8	det	_
5	novel	novel	NN	p2=JJ	8	amod	_
6	antifibrotic	antifibrotic	JJ	p2=NN	7	amod	_
7	drug	drug	NN	_	8	nn	_
8	pirfenidone	pirfenidone	NN	p2=NNS	2	appos	_
9	(	(	-LRB-	_	10	punct	_
10	Esbriet	esbriet	NNP	p2=NN	8	appos	_
11	)	)	-RRB-	_	10	punct	_
12	slowed	slow	VBD	pb=slow.02	0	root	_
13	progression	progression	NN	_	12	dobj	12:A1=PPT
14	of	of	IN	_	13	prep	_
15	idiopathic	idiopathic	JJ	p2=VBG	17	amod	_
16	pulmonary	pulmonary	JJ	_	17	amod	_
17	fibrosis	fibrosis	NN	_	14	pobj	_
18	(	(	-LRB-	_	17	punct	_
19	IPF	ipf	NNP	p2=PRP	17	appos	_
20	)	)	-RRB-	_	17	punct	_
21	in	in	IN	_	12	prep	12:AM-LOC
22	the	the	DT	_	24	det	_
23	ASCEND	ascend	NNP	_	24	nn	_
24	trial	trial	NN	_	21	pobj	28:A0
25	,	,	,	_	24	punct	_
26	which	which	WDT	_	28	nsubj	28:R-A0
27	also	also	RB	_	28	advmod	28:AM-DIS
28	turned	turn	VBD	pb=turn.06	24	rcmod	_
29	up	up	RP	_	28	prt	28:C-V
30	a	a	DT	_	32	det	_
31	survival	survival	NN	_	32	nn	_
32	benefit	benefit	NN	_	28	dobj	28:A1=PPT
33	when	when	WRB	_	34	advmod	34:R-AM-TMP
34	pooled	pool	VBN	pb=pool.01	28	advcl	28:AM-TMP
35	with	with	IN	_	34	prep	34:A1=PPT
36	prior	prior	JJ	p2=RB	38	amod	_
37	pivotal	pivotal	JJ	_	38	amod	_
38	trials	trial	NNS	_	35	pobj	_
39	.	.	.	_	12	punct	_

1	While	while	IN	_	6	mark	_
2	the	the	DT	_	3	det	_
3	trial	trial	NN	_	6	nsubj	6:A0=CAU
4	did	do	VBD	_	6	aux	_
5	n't	not	RB	_	6	neg	6:AM-NEG
6	show	show	VB	pb=show.01	31	advcl	31:AM-ADV
7	an	an	DT	_	8	det	_
8	improvement	improvement	NN	_	6	dobj	6:A1=PPT
9	in	in	IN	_	8	prep	_
10	overall	overall	JJ	p2=NN	15	amod	_
11	or	or	CC	_	10	cc	_
12	disease	disease	NN	p2=JJ	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	specific	specific	JJ	_	10	conj	_
15	survival	survival	NN	_	9	pobj	_
16	,	,	,	_	15	punct	_
17	a	a	DT	_	19	det	_
18	pooled	pool	VBN	p2=JJ|pb=pool.01	19	amod	_
19	analysis	analysis	NN	_	15	appos	18:A1=PPT
20	with	with	IN	_	19	prep	_
21	the	the	DT	_	25	det	_
22	two	#crd#	CD	_	25	num	_
23	prior	prior	JJ	p2=RB	25	amod	_
24	pivotal	pivotal	JJ	_	25	amod	_
25	trials	trial	NNS	_	20	pobj	_
26	(	(	-LRB-	_	25	punct	_
27	CAPACITY	capacity	NNP	p2=NN	28	nn	_
28	trials	trial	NNS	_	25	appos	_
29	)	)	-RRB-	_	25	punct	_
30	did	do	VBD	_	31	aux	_
31	favor	favor	VB	p2=NN|pb=favor.01	38	ccomp	_
32	pirfenidone	pirfenidone	NN	p2=VBN	31	dobj	31:A1=PAG
33	on	on	IN	_	31	prep	_
34	both	both	DT	p2=CC	35	det	_
35	counts	count	NNS	_	33	pobj	_
36	,	,	,	_	38	punct	_
37	they	they	PRP	_	38	nsubj	38:A0=PAG
38	reported	report	VBD	pb=report.01	0	root	_
39	at	at	IN	_	38	prep	38:AM-LOC
40	the	the	DT	_	44	det	_
41	American	american	NNP	p2=JJ	43	nn	_
42	Thoracic	thoracic	NNP	_	43	nn	_
43	Society	society	NNP	_	44	nn	_
44	meeting	meeting	NN	p2=VBG	39	pobj	_
45	and	and	CC	_	38	cc	_
46	simultaneously	simultaneously	RB	_	47	advmod	_
47	online	online	RB	p2=JJ	38	advmod	_
48	in	in	IN	_	47	prep	_
49	the	the	DT	_	52	det	_
50	New	new	NNP	_	51	nn	_
51	England	england	NNP	_	52	nn	_
52	Journal	journal	NNP	_	48	pobj	_
53	of	of	IN	_	52	prep	_
54	Medicine	medicine	NNP	_	53	pobj	_
55	.	.	.	_	38	punct	_

1	Across	across	IN	_	8	prep	8:AM-LOC
2	the	the	DT	_	5	det	_
3	pooled	pool	VBN	p2=JJ|pb=pool.01	5	amod	_
4	1,247	0	CD	_	5	num	_
5	patients	patient	NNS	_	1	pobj	3:A1=PPT
6	,	,	,	_	8	punct	_
7	pirfenidone	pirfenidone	NN	p2=NNP	8	nsubj	8:A0
8	reduced	reduce	VBD	pb=reduce.01	0	root	_
9	the	the	DT	_	10	det	_
10	risk	risk	NN	_	8	dobj	8:A1=PPT
11	of	of	IN	_	10	prep	_
12	death	death	NN	_	11	pobj	_
13	at	at	IN	_	8	prep	8:AM-TMP
14	1	0	CD	_	15	num	_
15	year	year	NN	_	13	pobj	_
16	by	by	IN	_	8	prep	8:AM-MNR
17	a	a	DT	_	20	det	_
18	relative	relative	JJ	_	20	amod	_
19	48	0	CD	_	20	num	_
20	%	%	NN	_	21	npadvmod	_
21	overall	overall	JJ	p2=NN	16	pobj	_
22	and	and	CC	_	21	cc	_
23	by	by	IN	_	21	conj	_
24	68	0	CD	_	25	num	_
25	%	%	NN	_	23	pobj	_
26	for	for	IN	_	25	prep	_
27	death	death	NN	_	26	pobj	_
28	from	from	IN	_	27	prep	_
29	IPF	ipf	NNP	_	28	pobj	_
30	(	(	-LRB-	_	29	punct	_
31	P=0.01	p=0.01	NNP	p2=NN	29	appos	_
32	and	and	CC	_	31	cc	_
33	P=0.006	p=0.006	NNP	p2=NN	31	conj	_
34	)	)	-RRB-	_	29	punct	_
35	.	.	.	_	8	punct	_

1	These	these	DT	_	2	det	_
2	results	result	NNS	_	4	nsubj	4:A1=PPT
3	closely	closely	RB	_	4	advmod	4:AM-MNR
4	matched	match	VBN	p2=VBD|pb=match.01	0	root	_
5	topline	topline	NN	p2=PRP$	6	nn	_
6	results	result	NNS	_	4	dobj	7:A1=PPT;4:C-A1
7	released	release	VBN	pb=release.01	6	partmod	_
8	in	in	IN	_	7	prep	7:AM-TMP
9	February	february	NNP	_	8	pobj	_
10	.	.	.	_	4	punct	_

1	These	these	DT	_	2	nsubj	2:A1=PPT
2	are	be	VBP	pb=be.01	27	ccomp	27:A1=PPT
3	game	game	NN	_	5	hmod	_
4	-	-	HYPH	_	5	hyph	_
5	changing	change	VBG	p2=NN	6	amod	_
6	results	result	NNS	_	2	attr	2:A2=PRD
7	for	for	IN	_	6	prep	_
8	IPF	ipf	NNP	_	7	pobj	_
9	,	,	,	_	8	punct	_
10	Gary	gary	NNP	_	12	nn	_
11	M.	m.	NNP	_	12	nn	_
12	Hunninghake	hunninghake	NNP	_	8	conj	_
13	,	,	,	_	12	punct	_
14	MD	md	NNP	_	12	conj	_
15	,	,	,	_	14	punct	_
16	MPH	mph	NNP	_	14	conj	_
17	,	,	,	_	16	punct	_
18	of	of	IN	_	16	prep	_
19	Brigham	brigham	NNP	p2=NN	18	pobj	_
20	and	and	CC	_	16	cc	_
21	Women	women	NNP	p2=NNPS	23	poss	_
22	's	's	POS	_	21	possessive	_
23	Hospital	hospital	NNP	_	16	conj	_
24	in	in	IN	_	23	prep	_
25	Boston	boston	NNP	_	24	pobj	_
26	,	,	,	_	27	punct	_
27	wrote	write	VBD	pb=write.01	0	root	_
28	in	in	IN	p2=RP	27	prep	27:R-AM-LOC
29	an	an	DT	_	31	det	_
30	accompanying	accompany	VBG	p2=JJ|pb=accompany.01	31	amod	_
31	editorial	editorial	NN	_	28	pobj	30:A0=PAG;35:A1=PPT
32	,	,	,	_	31	punct	_
33	especially	especially	RB	_	35	advmod	_
34	when	when	WRB	_	35	advmod	35:R-AM-TMP
35	paired	pair	VBN	pb=pair.01	31	partmod	_
36	with	with	IN	_	35	prep	35:A2=PPT
37	results	result	NNS	_	36	pobj	_
38	from	from	IN	_	37	prep	_
39	two	#crd#	CD	_	42	num	_
40	other	other	JJ	_	42	amod	_
41	positive	positive	JJ	_	42	amod	_
42	trials	trial	NNS	_	38	pobj	_
43	on	on	IN	_	42	prep	_
44	the	the	DT	_	49	det	_
45	novel	novel	NN	p2=JJ	49	nn	_
46	tyrosine	tyrosine	NN	p2=PRP	47	nn	_
47	kinase	kinase	NN	p2=VBD	49	nn	_
48	inhibitor	inhibitor	NN	p2=CC	49	nn	_
49	nintedanib	nintedanib	NN	p2=CD	43	pobj	52:A1
50	(	(	-LRB-	_	49	punct	_
51	also	also	RB	_	52	advmod	52:AM-DIS
52	reported	report	VBN	p2=VBD|pb=report.01	49	partmod	_
53	at	at	IN	_	52	prep	52:AM-LOC
54	the	the	DT	_	55	det	_
55	ATS	ats	NNP	_	53	pobj	_
56	late	late	RB	p2=JJ	58	hmod	_
57	-	-	HYPH	_	58	hyph	_
58	breaking	break	VBG	_	59	amod	_
59	session	session	NN	_	53	pobj	_
60	and	and	CC	_	53	cc	_
61	in	in	IN	_	53	conj	_
62	the	the	DT	_	63	det	_
63	NEJM	nejm	NNP	p2=NN	61	pobj	_
64	)	)	-RRB-	_	49	punct	_
65	.	.	.	_	27	punct	_

1	The	the	DT	_	2	det	_
2	disease	disease	NN	_	3	nsubj	3:A0=PAG
3	has	have	VBZ	pb=have.03	0	root	_
4	a	a	DT	_	6	det	_
5	death	death	NN	_	6	nn	_
6	rate	rate	NN	_	3	dobj	3:A1=PPT
7	worse	bad	JJR	_	6	amod	_
8	than	than	IN	_	7	prep	_
9	many	many	JJ	_	10	amod	_
10	cancers	cancer	NNS	_	8	pobj	_
11	,	,	,	_	10	punct	_
12	with	with	IN	_	10	prep	_
13	3	0	CD	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	year	year	NN	_	16	nn	_
16	survival	survival	NN	_	12	pobj	_
17	of	of	IN	_	16	prep	_
18	50	0	CD	_	19	num	_
19	%	%	NN	_	17	pobj	_
20	.	.	.	_	3	punct	_

1	But	but	CC	_	18	cc	18:AM-DIS
2	"	"	``	_	18	punct	_
3	beyond	beyond	IN	_	18	prep	18:AM-ADV
4	providing	provide	VBG	p2=JJ|pb=provide.01	3	pcomp	_
5	information	information	NN	_	4	dobj	4:A1=PPT
6	about	about	IN	_	5	prep	_
7	prognosis	prognosis	NN	_	6	pobj	_
8	or	or	CC	_	7	cc	_
9	referral	referral	NN	_	7	conj	_
10	for	for	IN	_	7	prep	_
11	lung	lung	NN	_	12	nn	_
12	transplantation	transplantation	NN	_	10	pobj	_
13	or	or	CC	_	12	cc	_
14	palliation	palliation	NN	_	12	conj	_
15	,	,	,	_	18	punct	_
16	there	there	EX	_	18	expl	_
17	has	have	VBZ	_	18	aux	_
18	been	be	VBN	pb=be.02	30	ccomp	30:A1=PPT
19	little	little	JJ	_	18	acomp	18:A1=PPT
20	to	to	TO	_	21	aux	_
21	offer	offer	VB	pb=offer.01	19	infmod	_
22	in	in	IN	_	21	prep	21:AM-MNR
23	the	the	DT	_	24	det	_
24	way	way	NN	_	22	pobj	_
25	of	of	IN	_	24	prep	_
26	treatment	treatment	NN	_	25	pobj	_
27	,	,	,	_	30	punct	_
28	"	"	''	_	30	punct	_
29	he	he	PRP	_	30	nsubj	30:A0
30	said	say	VBD	pb=say.01	0	root	_
31	.	.	.	_	30	punct	_

1	The	the	DT	_	3	det	_
2	new	new	JJ	_	3	amod	_
3	findings	finding	NNS	_	4	nsubj	4:A0=PAG
4	offer	offer	VBP	pb=offer.01	24	ccomp	24:A1=PPT
5	hope	hope	VB	p2=NN	4	dobj	4:A1=PPT
6	that	that	IN	_	11	complm	_
7	"	"	``	p2=''	11	punct	_
8	we	we	PRP	_	11	nsubj	11:A0=PAG
9	may	may	MD	_	11	aux	11:AM-MOD
10	soon	soon	RB	_	11	advmod	11:AM-TMP
11	have	have	VB	pb=have.03	5	ccomp	_
12	choices	choice	NNS	_	11	dobj	11:A1=PPT
13	in	in	IN	_	12	prep	_
14	the	the	DT	_	16	det	_
15	medical	medical	JJ	_	16	amod	_
16	management	management	NN	_	13	pobj	_
17	of	of	IN	_	16	prep	_
18	idiopathic	idiopathic	JJ	p2=VBG	20	amod	_
19	pulmonary	pulmonary	JJ	_	20	amod	_
20	fibrosis	fibrosis	NN	_	17	pobj	_
21	,	,	,	_	24	punct	_
22	"	"	''	_	24	punct	_
23	he	he	PRP	_	24	nsubj	24:A0
24	said	say	VBD	pb=say.01	0	root	_
25	.	.	.	_	24	punct	_

1	The	the	DT	_	2	det	_
2	trial	trial	NN	_	3	nsubj	3:A1=PPT
3	was	be	VBD	pb=be.01	0	root	_
4	drugmaker	drugmaker	JJR	p2=NN	3	acomp	3:A2=PRD
5	InterMune	intermune	NNP	_	7	poss	_
6	's	's	POS	_	5	possessive	_
7	response	response	NN	_	3	attr	_
8	to	to	IN	_	7	prep	_
9	the	the	DT	_	10	det	_
10	FDA	fda	NNP	_	13	poss	_
11	's	's	POS	_	10	possessive	_
12	2010	0	CD	_	13	num	_
13	refusal	refusal	NN	_	8	pobj	_
14	to	to	TO	_	15	aux	_
15	approve	approve	VB	pb=approve.01	13	infmod	_
16	pirfenidone	pirfenidone	NN	p2=VBN	15	dobj	15:A1=PPT
17	in	in	IN	_	15	prep	15:AM-LOC
18	IPF	ipf	NNP	_	17	pobj	_
19	on	on	IN	_	15	prep	15:AM-TMP
20	the	the	DT	_	21	det	_
21	basis	basis	NN	_	19	pobj	_
22	of	of	IN	_	21	prep	_
23	two	#crd#	CD	_	26	num	_
24	prior	prior	JJ	p2=RB	26	amod	_
25	multinational	multinational	JJ	_	26	amod	_
26	trials	trial	NNS	_	22	pobj	32:A0=CAU;30:A1=PPT
27	,	,	,	_	26	punct	_
28	which	which	WDT	_	32	nsubj	32:R-A0
29	,	,	,	_	32	punct	_
30	combined	combine	VBN	p2=VBD|pb=combine.01	32	advcl	_
31	,	,	,	_	32	punct	_
32	showed	show	VBD	pb=show.01	26	rcmod	_
33	only	only	RB	_	36	advmod	_
34	a	a	DT	_	36	det	_
35	small	small	JJ	_	36	amod	_
36	difference	difference	NN	_	32	dobj	32:A1=PPT
37	in	in	IN	_	36	prep	_
38	the	the	DT	_	40	det	_
39	surrogate	surrogate	JJ	p2=NN	40	amod	_
40	endpoint	endpoint	NN	_	37	pobj	_
41	and	and	CC	_	36	cc	_
42	no	no	DT	_	43	det	_
43	differences	difference	NNS	_	36	conj	_
44	in	in	IN	_	43	prep	_
45	hard	hard	JJ	p2=RB	46	amod	_
46	endpoints	endpoint	NNS	_	44	pobj	_
47	like	like	IN	p2=VBP	46	prep	_
48	exacerbations	exacerbation	NNS	_	47	pobj	_
49	,	,	,	_	48	punct	_
50	lung	lung	NN	p2=VBG	51	nn	_
51	transplantation	transplantation	NN	_	48	conj	_
52	,	,	,	_	51	punct	_
53	and	and	CC	_	51	cc	_
54	mortality	mortality	NN	_	51	conj	_
55	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	question	question	NN	_	4	nsubj	4:A1=PPT
3	now	now	RB	_	4	advmod	4:AM-TMP
4	is	be	VBZ	pb=be.01	0	root	_
5	whether	whether	IN	_	10	complm	_
6	the	the	DT	_	8	det	_
7	new	new	JJ	_	8	amod	_
8	results	result	NNS	_	10	nsubj	13:A0=PAG;10:A1=PPT
9	will	will	MD	_	10	aux	10:AM-MOD
10	be	be	VB	pb=be.01	4	ccomp	4:A2=PRD
11	enough	enough	JJ	p2=RB	10	acomp	10:A2=PRD
12	to	to	TO	_	13	aux	_
13	tip	tip	VB	pb=tip.01	11	xcomp	_
14	the	the	DT	_	15	det	_
15	balance	balance	NN	_	13	dobj	13:A1=PPT
16	in	in	IN	_	13	prep	13:A2=GOL
17	favor	favor	NN	_	16	pobj	_
18	of	of	IN	_	17	prep	_
19	pirfenidone	pirfenidone	NN	p2=NNP	18	pobj	_
20	for	for	IN	_	19	prep	_
21	the	the	DT	_	22	det	_
22	FDA	fda	NNP	_	20	pobj	_
23	.	.	.	_	4	punct	_

1	"	"	``	_	25	punct	_
2	We	we	PRP	_	3	nsubj	3:A0=PAG
3	did	do	VBD	pb=do.02	25	ccomp	_
4	exactly	exactly	RB	_	5	advmod	_
5	what	what	WP	_	10	dobj	10:R-A1
6	they	they	PRP	_	7	nsubj	7:A0=PAG
7	asked	ask	VBD	pb=ask.02	3	ccomp	3:A1=PPT
8	us	us	PRP	_	7	dobj	10:A0=PAG;7:A2=GOL
9	to	to	TO	_	10	aux	_
10	do	do	VB	pb=do.02	7	xcomp	7:A1=PPT
11	,	,	,	_	3	punct	_
12	and	and	CC	_	3	cc	_
13	the	the	DT	_	14	det	_
14	results	result	NNS	_	15	nsubj	15:A1=PPT
15	are	be	VBP	pb=be.01	3	conj	_
16	even	even	RB	_	17	advmod	_
17	more	more	RBR	_	18	advmod	_
18	positive	positive	JJ	_	15	acomp	15:A2=PRD
19	than	than	IN	_	21	mark	_
20	we	we	PRP	_	21	nsubj	21:A0
21	expected	expect	VBD	pb=expect.01	18	advcl	_
22	,	,	,	_	25	punct	_
23	"	"	``	p2=''	25	punct	_
24	King	king	NNP	p2=NN	25	nsubj	25:A0=PAG
25	told	tell	VBD	pb=tell.01	0	root	_
26	MedPage	medpage	NNP	_	25	dobj	25:A2=GOL
27	Today	today	NNP	p2=NN	25	npadvmod	25:AM-TMP
28	.	.	.	_	25	punct	_

1	"	"	``	_	5	punct	_
2	So	so	RB	_	5	advmod	5:AM-DIS
3	I	I	PRP	_	5	nsubj	5:A0
4	would	would	MD	_	5	aux	5:AM-MOD
5	think	think	VB	pb=think.01	0	root	_
6	the	the	DT	_	7	det	_
7	FDA	fda	NNP	_	9	nsubj	9:A0=PPT
8	would	would	MD	_	9	aux	9:AM-MOD
9	look	look	VB	pb=look.01	5	ccomp	5:A1=PPT
10	favorably	favorably	RB	_	9	advmod	9:AM-MNR
11	on	on	IN	_	9	prep	9:A1=GOL
12	this	this	DT	_	13	det	_
13	compound	compound	NN	_	11	pobj	_
14	.	.	.	_	5	punct	_
15	"	"	''	_	5	punct	_

1	His	his	PRP$	_	2	poss	_
2	group	group	NN	_	3	nsubj	3:A0=PAG
3	argued	argue	VBD	pb=argue.01	0	root	_
4	that	that	IN	_	6	complm	_
5	they	they	PRP	_	6	nsubj	6:A0=PAG
6	used	use	VBD	pb=use.01	3	ccomp	3:A1=PPT
7	"	"	``	p2=''	14	punct	_
8	reliable	reliable	JJ	_	14	amod	_
9	,	,	,	_	8	punct	_
10	valid	valid	JJ	_	8	conj	_
11	,	,	,	_	10	punct	_
12	and	and	CC	_	10	cc	_
13	responsive	responsive	JJ	_	10	conj	_
14	measures	measure	NNS	_	6	dobj	6:A1=PPT
15	of	of	IN	_	14	prep	_
16	disease	disease	NN	p2=JJ	17	nn	_
17	status	status	NN	_	15	pobj	_
18	and	and	CC	_	17	cc	_
19	independent	independent	JJ	_	20	amod	_
20	predictors	predictor	NNS	_	17	conj	_
21	of	of	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	risk	risk	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	death	death	NN	_	24	pobj	_
26	"	"	''	p2=``	14	punct	_
27	in	in	IN	_	6	prep	_
28	IPF	ipf	NNP	p2=NN	27	pobj	_
29	--	--	:	_	6	punct	_
30	FVC	fvc	NNP	p2=NN	6	dobj	_
31	and	and	CC	_	30	cc	_
32	6	0	CD	_	34	hmod	_
33	-	-	HYPH	_	34	hyph	_
34	minute	minute	NN	_	36	nn	_
35	walk	walk	NN	p2=VB	36	nn	_
36	distance	distance	NN	_	30	conj	_
37	--	--	:	p2=,	30	punct	_
38	and	and	CC	_	30	cc	_
39	found	find	VBN	p2=VBD|pb=find.01	40	amod	_
40	effects	effect	NNS	_	30	conj	39:A1=PPT
41	"	"	''	p2=``	40	punct	_
42	well	well	RB	p2=UH	43	advmod	_
43	above	above	IN	_	40	prep	_
44	the	the	DT	_	49	det	_
45	estimated	estimate	VBN	p2=JJ|pb=estimate.01	49	amod	_
46	minimal	minimal	JJ	_	49	amod	_
47	clinically	clinically	RB	_	48	advmod	_
48	important	important	JJ	_	49	amod	_
49	difference	difference	NN	_	43	pobj	45:A1=PPT
50	for	for	IN	_	49	prep	_
51	each	each	DT	_	50	pobj	_
52	.	.	.	_	3	punct	_
53	"	"	''	_	3	punct	_

1	NEJM	nejm	NNP	p2=NN	2	nn	_
2	editor-in-chief	editor-in-chief	NN	p2=HYPH	5	nn	_
3	Jeffrey	jeffrey	NNP	_	5	nn	_
4	M.	m.	NNP	_	5	nn	_
5	Drazen	drazen	NNP	_	9	nsubj	9:A0=PAG;17:A0=PAG
6	,	,	,	_	5	punct	_
7	MD	md	NNP	_	5	appos	_
8	,	,	,	_	5	punct	_
9	had	have	VBD	pb=have.03	0	root	_
10	high	high	JJ	_	11	amod	_
11	praise	praise	NN	_	9	dobj	9:A1=PPT
12	for	for	IN	_	11	prep	_
13	the	the	DT	_	14	det	_
14	study	study	NN	_	12	pobj	_
15	overall	overall	RB	p2=NN	14	advmod	_
16	,	,	,	_	9	punct	_
17	calling	call	VBG	pb=call.01	9	advcl	9:AM-ADV
18	the	the	DT	_	19	det	_
19	results	result	NNS	_	17	dobj	17:A1=PPT
20	"	"	``	p2=''	23	punct	_
21	really	really	RB	_	22	advmod	_
22	good	good	JJ	_	23	amod	_
23	news	news	NN	_	17	oprd	17:A2=PRD
24	"	"	''	_	23	punct	_
25	and	and	CC	_	23	cc	_
26	"	"	``	_	27	punct	_
27	groundbreaking	groundbreaking	NN	p2=VBG	23	conj	_
28	.	.	.	_	9	punct	_
29	"	"	''	_	9	punct	_

1	However	however	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	he	he	PRP	_	4	nsubj	4:A0=PAG
4	urged	urge	VBD	pb=urge.01	0	root	_
5	researchers	researcher	NNS	_	4	dobj	8:A0=PAG;11:A0=PAG;4:A1=PPT
6	not	not	RB	_	8	neg	8:AM-NEG
7	to	to	TO	p2=IN	8	aux	_
8	rest	rest	VB	pb=rest.01	4	xcomp	4:A2=PPT
9	upon	upon	IN	_	8	prep	8:A1=PPT
10	just	just	RB	_	11	advmod	11:AM-ADV
11	slowing	slow	VBG	pb=slow.01	9	pcomp	_
12	the	the	DT	_	13	det	_
13	disease	disease	NN	_	11	dobj	11:A1=PPT
14	.	.	.	_	4	punct	_

1	"	"	``	_	25	punct	_
2	It	it	PRP	_	3	nsubj	_
3	's	be	VBZ	pb=be.01	25	ccomp	25:A1=PPT
4	great	great	JJ	_	3	acomp	3:A2=PRD
5	,	,	,	_	8	punct	_
6	you	you	PRP	_	8	nsubj	8:A0=PAG
7	're	be	VBP	_	8	aux	_
8	having	have	VBG	pb=have.03	15	ccomp	_
9	a	a	DT	_	11	det	_
10	significant	significant	JJ	_	11	amod	_
11	impact	impact	NN	_	8	dobj	8:A1=PPT
12	,	,	,	_	15	punct	_
13	you	you	PRP	_	15	nsubj	15:A0=PAG
14	're	be	VBP	_	15	aux	_
15	halving	halve	VBG	pb=halve.01	3	ccomp	3:A1=PPT
16	the	the	DT	_	18	det	_
17	death	death	NN	_	18	nn	_
18	rate	rate	NN	_	15	dobj	15:A1=PPT
19	over	over	IN	_	15	prep	15:AM-TMP
20	this	this	DT	_	21	det	_
21	time	time	NN	_	19	pobj	_
22	,	,	,	_	25	punct	_
23	"	"	''	p2=WRB	25	punct	_
24	he	he	PRP	_	25	nsubj	25:A0
25	said	say	VBD	pb=say.01	0	root	_
26	.	.	.	_	25	punct	_

1	"	"	``	p2=''	5	punct	_
2	But	but	CC	_	5	cc	5:AM-DIS
3	these	these	DT	_	4	det	_
4	people	people	NNS	_	5	nsubj	5:A0=PAG
5	have	have	VBP	p2=VB|pb=have.03	0	root	_
6	a	a	DT	_	8	det	_
7	death	death	NN	_	8	nn	_
8	sentence	sentence	NN	_	5	dobj	5:A1=PPT
9	,	,	,	_	12	punct	_
10	they	they	PRP	_	12	nsubj	12:A0=PAG
11	just	just	RB	_	12	advmod	12:AM-ADV
12	have	have	VBP	pb=have.03	5	conj	_
13	longer	long	RBR	p2=JJR	12	dobj	12:A1=PPT
14	.	.	.	_	12	punct	_

1	They	they	PRP	_	2	nsubj	4:A0=PAG
2	get	get	VBP	pb=get.06	0	root	_
3	to	to	TO	_	4	aux	_
4	live	live	VB	pb=live.01	2	xcomp	2:A1=PRD
5	with	with	IN	_	4	prep	4:AM-MNR
6	their	their	PRP$	_	7	poss	_
7	disease	disease	NN	_	5	pobj	_
8	longer	long	RBR	p2=RB	4	advmod	4:AM-TMP
9	before	before	IN	p2=RB	11	mark	_
10	it	it	PRP	_	11	nsubj	11:A0=PAG
11	does	do	VBZ	pb=do.02	4	advcl	4:AM-TMP
12	them	them	PRP	_	11	dobj	11:A1=PPT
13	in	in	RP	p2=IN	11	advmod	_
14	.	.	.	_	2	punct	_

1	We	we	PRP	_	4	nsubj	4:A0=PAG
2	ca	can	MD	_	4	aux	4:AM-MOD
3	n't	not	RB	_	4	neg	4:AM-NEG
4	quit	quit	VB	pb=quit.01	0	root	_
5	.	.	.	_	4	punct	_
6	"	"	''	_	4	punct	_

1	ASCEND	ascend	VB	p2=NN	2	nsubj	2:A0=PAG
2	randomized	randomize	VBD	p2=VBN|pb=randomize.01	0	root	_
3	555	0	CD	_	4	num	_
4	patients	patient	NNS	_	2	dobj	2:A1=PPT
5	with	with	IN	_	2	prep	2:A2=GOL
6	centrally	centrally	RB	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	confirmed	confirm	VBN	_	9	amod	_
9	IPF	ipf	NNP	p2=NN	5	pobj	_
10	to	to	TO	_	11	aux	_
11	receive	receive	VB	pb=receive.01	2	advcl	2:AM-PRP
12	either	either	CC	p2=DT	14	preconj	_
13	oral	oral	JJ	p2=VB	14	amod	_
14	pirfenidone	pirfenidone	NN	p2=FW	11	dobj	11:A1=PPT
15	(	(	-LRB-	_	21	punct	_
16	a	a	DT	_	17	det	_
17	total	total	NN	_	21	nsubj	21:A1=PPT
18	of	of	IN	_	17	prep	_
19	2,403	0	CD	_	20	num	_
20	mg	mg	NNS	p2=NN	18	pobj	_
21	divided	divide	VBN	p2=VBD|pb=divide.02	14	parataxis	_
22	into	into	IN	_	21	prep	21:A2=GOL
23	three	#crd#	CD	_	24	num	_
24	doses	dose	NNS	_	22	pobj	_
25	daily	daily	JJ	p2=RB	24	amod	_
26	)	)	-RRB-	_	21	punct	_
27	or	or	CC	_	14	cc	_
28	placebo	placebo	NN	p2=VB	14	conj	_
29	for	for	IN	_	28	prep	_
30	1	0	CD	_	31	num	_
31	year	year	NN	_	29	pobj	_
32	.	.	.	_	2	punct	_

1	Patients	patient	NNS	_	3	nsubjpass	3:A1=PPT;5:A1=PPT
2	were	be	VBD	_	3	auxpass	_
3	allowed	allow	VBN	pb=allow.01	0	root	_
4	to	to	TO	_	5	aux	_
5	stay	stay	VB	pb=stay.01	3	xcomp	3:C-A1
6	on	on	IN	p2=RP	5	prep	5:A3
7	other	other	JJ	_	9	amod	_
8	IPF	ipf	NNP	p2=IN	9	nn	_
9	drugs	drug	NNS	p2=VBZ	6	pobj	_
10	only	only	RB	_	12	advmod	_
11	if	if	IN	_	12	mark	_
12	used	use	VBN	pb=use.01	5	advcl	_
13	for	for	IN	_	12	prep	12:A2=PRP
14	another	another	DT	_	15	det	_
15	indication	indication	NN	_	13	pobj	_
16	without	without	IN	_	15	prep	_
17	an	an	DT	_	19	det	_
18	acceptable	acceptable	JJ	_	19	amod	_
19	alternative	alternative	NN	_	16	pobj	_
20	.	.	.	_	3	punct	_

1	While	while	IN	_	5	mark	_
2	the	the	DT	_	4	det	_
3	primary	primary	JJ	p2=NN	4	amod	_
4	endpoint	endpoint	NN	_	5	nsubj	5:A0=PAG
5	sought	seek	VBD	pb=seek.01	22	advcl	22:AM-TMP
6	a	a	DT	_	7	det	_
7	slowing	slowing	NN	_	5	dobj	5:A1=PPT
8	in	in	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	progressive	progressive	JJ	_	11	amod	_
11	loss	loss	NN	_	8	pobj	_
12	of	of	IN	_	11	prep	_
13	lung	lung	NN	_	14	nn	_
14	function	function	NN	_	12	pobj	15:A1
15	seen	see	VBN	pb=see.01	14	partmod	_
16	from	from	IN	_	15	prep	15:AM-DIR
17	fibrotic	fibrotic	JJ	p2=NN	18	amod	_
18	scarring	scarring	NN	p2=VBG	16	pobj	_
19	,	,	,	_	22	punct	_
20	pirfenidone	pirfenidone	NN	p2=NNP	22	nsubj	22:A0=PAG
21	substantially	substantially	RB	_	22	advmod	_
22	increased	increase	VBD	pb=increase.01	0	root	_
23	the	the	DT	_	24	det	_
24	proportion	proportion	NN	_	22	dobj	22:A1=PPT
25	of	of	IN	_	24	prep	_
26	patients	patient	NNS	_	25	pobj	_
27	with	with	IN	_	22	prep	22:A2=EXT
28	no	no	DT	_	29	det	_
29	decline	decline	NN	_	27	pobj	_
30	in	in	IN	_	29	prep	_
31	FVC	fvc	NNP	_	30	pobj	_
32	(	(	-LRB-	_	34	punct	_
33	22.7	0	CD	_	34	num	_
34	%	%	NN	_	31	parataxis	_
35	versus	versus	IN	p2=NN	34	prep	_
36	9.7	0	CD	_	37	num	_
37	%	%	NN	_	35	pobj	_
38	,	,	,	_	34	punct	_
39	P	p	NN	p2=NNP	34	conj	_
40	<	<	XX	p2=SYM	41	nmod	_
41	0.001	0	CD	_	39	num	_
42	)	)	-RRB-	_	34	punct	_
43	.	.	.	_	22	punct	_

1	Key	key	JJ	p2=NNP	3	amod	_
2	secondary	secondary	JJ	_	3	amod	_
3	endpoints	endpoint	NNS	p2=VBZ	5	nsubj	5:A1=PPT
4	also	also	RB	_	5	advmod	5:AM-DIS
5	improved	improve	VBD	p2=VBN|pb=improve.01	0	root	_
6	with	with	IN	_	5	prep	5:AM-COM
7	the	the	DT	_	8	det	_
8	drug	drug	NN	_	6	pobj	_
9	compared	compare	VBN	_	5	prep	5:AM-ADV
10	with	with	IN	_	9	prep	_
11	placebo	placebo	NN	_	10	pobj	_
12	.	.	.	_	5	punct	_

1	Pirfenidone	pirfenidone	NNP	p2=NN	2	nsubj	2:A0
2	reduced	reduce	VBD	pb=reduce.01	0	root	_
3	the	the	DT	_	4	det	_
4	decline	decline	NN	_	2	dobj	2:A1=PPT
5	in	in	IN	_	4	prep	_
6	the	the	DT	_	11	det	_
7	6	0	CD	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	minute	minute	NN	_	11	nn	_
10	walk	walk	NN	p2=VB	11	nn	_
11	distance	distance	NN	_	5	pobj	_
12	at	at	IN	_	4	prep	_
13	week	week	NN	_	12	pobj	_
14	52	0	CD	_	13	num	_
15	,	,	,	_	2	punct	_
16	with	with	IN	_	2	prep	2:A4=GOL
17	25.9	0	CD	_	18	num	_
18	%	%	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	patients	patient	NNS	_	19	pobj	_
21	losing	lose	VBG	pb=lose.01	20	partmod	_
22	50	0	CD	_	23	num	_
23	m	m	NNS	p2=NN	21	dobj	21:A1=PPT
24	or	or	CC	_	23	cc	_
25	more	more	RBR	p2=JJR	23	num	_
26	or	or	CC	_	25	cc	_
27	dying	die	VBG	pb=die.01	25	conj	_
28	compared	compare	VBN	_	27	prep	27:AM-ADV
29	with	with	IN	_	28	prep	_
30	35.7	0	CD	_	31	num	_
31	%	%	NN	_	29	pobj	_
32	(	(	-LRB-	_	31	punct	_
33	P=0.04	p=0.04	NNP	p2=NN	31	appos	_
34	)	)	-RRB-	_	31	punct	_
35	.	.	.	_	2	punct	_

1	Overall	overall	RB	p2=JJ	5	amod	_
2	progression	progression	NN	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	free	free	JJ	_	5	amod	_
5	survival	survival	NN	_	18	nsubj	18:A0=CAU;7:A1=PPT
6	,	,	,	_	5	punct	_
7	defined	define	VBN	pb=define.01	5	partmod	_
8	as	as	IN	p2=RB	7	prep	7:A2=PRD
9	alive	alive	JJ	_	8	amod	_
10	without	without	IN	_	7	prep	7:AM-MNR
11	a	a	DT	_	15	det	_
12	10	0	CD	_	14	num	_
13	percentage	percentage	NN	_	14	nn	_
14	point	point	NN	_	15	nn	_
15	decrease	decrease	NN	p2=VBP	10	pobj	_
16	in	in	IN	_	15	prep	_
17	percent	percent	NN	_	16	pobj	_
18	predicted	predict	VBD	p2=VBN|pb=predict.01	0	root	_
19	FVC	fvc	NNP	_	23	nn	_
20	or	or	CC	_	19	cc	_
21	50	0	CD	_	22	num	_
22	m	m	NNS	p2=CD	23	nn	_
23	loss	loss	NN	p2=VBP	18	dobj	18:A1=PPT
24	in	in	IN	_	18	prep	_
25	6	0	CD	_	27	hmod	_
26	-	-	HYPH	p2=:	27	hyph	_
27	minute	minute	NN	_	29	nn	_
28	walk	walk	NN	p2=VB	29	nn	_
29	distance	distance	NN	_	24	pobj	_
30	,	,	,	_	32	punct	_
31	also	also	RB	_	32	advmod	32:AM-DIS
32	improved	improve	VBN	p2=VBD|pb=improve.01	18	ccomp	_
33	with	with	IN	_	32	prep	32:A1=PPT
34	the	the	DT	_	35	det	_
35	drug	drug	NN	_	33	pobj	_
36	compared	compare	VBN	_	32	prep	32:AM-ADV
37	with	with	IN	_	36	prep	_
38	placebo	placebo	NN	_	37	pobj	_
39	(	(	-LRB-	_	38	punct	_
40	hazard	hazard	NN	_	41	nn	_
41	ratio	ratio	NN	_	38	appos	_
42	0.57	0	CD	_	41	num	_
43	,	,	,	_	41	punct	_
44	95	0	CD	_	45	num	_
45	%	%	NN	_	19	conj	_
46	CI	ci	NNP	_	47	nn	_
47	0.43-0.77	0.43-0.77	NNP	p2=CD	45	appos	_
48	)	)	-RRB-	_	38	punct	_
49	.	.	.	_	18	punct	_

1	However	however	RB	_	7	advmod	7:AM-DIS
2	,	,	,	_	7	punct	_
3	the	the	DT	_	4	det	_
4	drug	drug	NN	_	7	nsubj	7:A0=PAG
5	did	do	VBD	_	7	aux	_
6	n't	not	RB	_	7	neg	7:AM-NEG
7	improve	improve	VB	pb=improve.01	0	root	_
8	dyspnea	dyspnea	NN	p2=FW	9	nn	_
9	scores	score	NNS	_	7	dobj	7:A1=PPT
10	(	(	-LRB-	_	9	punct	_
11	P=0.16	p=0.16	NNP	p2=VBP	9	appos	_
12	)	)	-RRB-	_	9	punct	_
13	or	or	CC	_	7	cc	_
14	rates	rate	NNS	_	7	conj	_
15	of	of	IN	_	14	prep	_
16	death	death	NN	_	15	pobj	_
17	from	from	IN	_	14	prep	_
18	any	any	DT	_	19	det	_
19	cause	cause	NN	p2=IN	17	pobj	_
20	(	(	-LRB-	_	19	punct	_
21	4.0	0	CD	_	22	num	_
22	%	%	NN	_	19	appos	_
23	versus	versus	IN	p2=NN	22	prep	_
24	7.2	0	CD	_	25	num	_
25	%	%	NN	_	23	pobj	_
26	,	,	,	_	25	punct	_
27	P=0.10	p=0.10	NNP	p2=NN	25	appos	_
28	)	)	-RRB-	_	19	punct	_
29	or	or	CC	_	17	cc	_
30	from	from	IN	_	17	conj	_
31	IPF	ipf	NNP	_	30	pobj	_
32	(	(	-LRB-	_	34	punct	_
33	1.1	0	CD	_	34	num	_
34	%	%	NN	_	31	parataxis	_
35	versus	versus	IN	p2=NN	14	prep	_
36	2.5	0	CD	_	37	num	_
37	%	%	NN	_	35	pobj	_
38	,	,	,	_	37	punct	_
39	P=0.23	p=0.23	NNP	p2=NN	37	appos	_
40	)	)	-RRB-	_	14	punct	_
41	.	.	.	_	7	punct	_

1	The	the	DT	_	6	det	_
2	most	most	RBS	_	3	advmod	_
3	common	common	JJ	_	6	amod	_
4	serious	serious	JJ	_	6	amod	_
5	adverse	adverse	JJ	_	6	amod	_
6	event	event	NN	_	8	nsubj	8:A0=PAG
7	was	be	VBD	_	8	aux	_
8	worsening	worsen	VBG	pb=worsen.01	0	root	_
9	IPF	ipf	NNP	_	8	dobj	8:A1=PPT
10	.	.	.	_	8	punct	_

1	But	but	CC	_	10	cc	10:AM-DIS
2	excluding	exclude	VBG	_	10	prep	10:AM-ADV
3	these	these	DT	_	4	det	_
4	events	event	NNS	_	2	pobj	_
5	,	,	,	_	10	punct	_
6	serious	serious	JJ	_	9	amod	_
7	adverse	adverse	JJ	_	9	amod	_
8	event	event	NN	_	9	nn	_
9	rates	rate	NNS	_	10	nsubj	10:A1=PPT
10	were	be	VBD	pb=be.01	0	root	_
11	about	about	RB	p2=IN	12	advmod	_
12	similar	similar	JJ	_	10	acomp	10:A2=PRD
13	between	between	IN	_	12	prep	_
14	pirfenidone	pirfenidone	NN	p2=NNS	13	pobj	_
15	and	and	CC	_	14	cc	_
16	placebo	placebo	NN	_	14	conj	_
17	(	(	-LRB-	_	14	punct	_
18	18.7	0	CD	_	19	num	_
19	%	%	NN	_	14	appos	_
20	versus	versus	IN	p2=NN	19	prep	_
21	20.2	0	CD	_	22	num	_
22	%	%	NN	_	20	pobj	_
23	)	)	-RRB-	_	14	punct	_
24	.	.	.	_	10	punct	_

1	Gastrointestinal	gastrointestinal	JJ	p2=NNP	5	amod	_
2	and	and	CC	_	1	cc	_
3	skin-related	skin-related	JJ	p2=VBD	1	conj	_
4	adverse	adverse	JJ	_	5	amod	_
5	events	event	NNS	_	6	nsubj	6:A1=PPT
6	were	be	VBD	pb=be.01	0	root	_
7	more	more	RBR	_	8	advmod	_
8	common	common	JJ	_	6	acomp	6:A2=PRD
9	with	with	IN	_	8	prep	_
10	pirfenidone	pirfenidone	NN	p2=JJ	11	nn	_
11	group	group	NN	_	9	pobj	_
12	than	than	IN	_	8	prep	_
13	placebo	placebo	NN	_	12	pobj	_
14	,	,	,	_	6	punct	_
15	but	but	CC	_	6	cc	_
16	these	these	DT	_	18	nsubj	18:A0=PAG
17	rarely	rarely	RB	_	18	advmod	18:AM-TMP
18	led	lead	VBD	p2=VBN|pb=lead.03	6	conj	_
19	to	to	IN	p2=TO	18	prep	18:A2=PRD
20	treatment	treatment	NN	_	21	nn	_
21	discontinuation	discontinuation	NN	_	19	pobj	_
22	and	and	CC	_	18	cc	_
23	none	none	NN	_	24	nsubj	24:A1=PPT
24	were	be	VBD	pb=be.01	18	conj	_
25	grade	grade	NN	_	24	attr	24:A2=PRD
26	4	0	CD	_	25	num	_
27	,	,	,	_	24	punct	_
28	as	as	IN	_	31	mark	_
29	the	the	DT	_	30	det	_
30	researchers	researcher	NNS	_	31	nsubj	31:A0=PAG
31	noted	note	VBD	pb=note.01	24	advcl	24:AM-ADV
32	.	.	.	_	18	punct	_

1	Grade	grade	NNP	p2=NN	4	nn	_
2	3	0	CD	_	1	num	_
3	GI	gi	NNP	_	4	nn	_
4	events	event	NNS	_	5	nsubj	5:A1=PPT
5	occurred	occur	VBD	pb=occur.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	5.4	0	CD	_	8	num	_
8	%	%	NN	_	6	pobj	_
9	versus	versus	IN	p2=NN	5	prep	5:AM-TMP
10	1.4	0	CD	_	11	num	_
11	%	%	NN	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	patients	patient	NNS	_	12	pobj	_
14	;	;	:	p2=,	5	punct	_
15	while	while	IN	_	20	mark	_
16	grade	grade	NN	_	19	nn	_
17	3	0	CD	_	16	num	_
18	skin-related	skin-related	JJ	p2=VBD	19	amod	_
19	events	event	NNS	_	20	nsubj	20:A1=PPT
20	occurred	occur	VBD	pb=occur.01	5	advcl	5:AM-TMP
21	in	in	IN	_	20	prep	20:AM-LOC
22	1.8	0	CD	_	23	num	_
23	%	%	NN	_	21	pobj	_
24	versus	versus	IN	p2=NN	23	prep	_
25	0.4	0	CD	_	26	num	_
26	%	%	NN	_	24	pobj	_
27	.	.	.	_	5	punct	_

1	Clinically	clinically	RB	p2=NNP	3	advmod	_
2	significant	significant	JJ	_	3	amod	_
3	elevations	elevation	NNS	_	7	nsubj	7:A1=PPT
4	in	in	IN	_	3	prep	_
5	aminotransferase	aminotransferase	NN	p2=JJ	6	nn	_
6	levels	level	NNS	_	4	pobj	_
7	occurred	occur	VBD	pb=occur.01	0	root	_
8	more	more	RBR	p2=JJR	7	advmod	7:AM-EXT
9	with	with	IN	_	7	prep	7:AM-MNR
10	pirfenidone	pirfenidone	NN	_	9	pobj	_
11	but	but	CC	_	7	cc	_
12	King	king	NNP	_	14	poss	_
13	's	's	POS	_	12	possessive	_
14	group	group	NN	_	15	nsubj	15:A0=PAG
15	noted	note	VBD	pb=note.01	7	conj	_
16	these	these	DT	p2=EX	17	nsubj	17:A1=PPT
17	were	be	VBD	pb=be.01	15	ccomp	15:A1=PPT
18	still	still	RB	_	17	advmod	17:AM-TMP
19	in	in	IN	p2=RB	17	prep	17:A2=PRD
20	"	"	``	_	19	punct	_
21	less	less	JJR	_	23	amod	_
22	than	than	IN	_	23	quantmod	_
23	3	0	CD	_	24	num	_
24	%	%	NN	_	19	pobj	_
25	of	of	IN	_	24	prep	_
26	patients	patient	NNS	_	25	pobj	_
27	,	,	,	_	15	punct	_
28	were	be	VBD	pb=be.01	15	conj	_
29	reversible	reversible	JJ	_	28	acomp	28:A2=PRD
30	,	,	,	_	28	punct	_
31	and	and	CC	_	28	cc	_
32	did	do	VBD	_	34	aux	_
33	not	not	RB	_	34	neg	34:AM-NEG
34	have	have	VB	pb=have.03	28	conj	_
35	clinically	clinically	RB	_	36	advmod	_
36	significant	significant	JJ	_	37	amod	_
37	consequences	consequence	NNS	_	34	dobj	34:A1=PPT
38	.	.	.	_	15	punct	_
39	"	"	''	_	15	punct	_

1	That	that	DT	_	2	det	_
2	ASCEND	ascend	NNP	p2=RB	3	nsubj	3:A0=PAG
3	succeeded	succeed	VBD	pb=succeed.01	24	ccomp	24:A1=PPT
4	where	where	WRB	_	10	advmod	10:R-AM-LOC
5	the	the	DT	_	9	det	_
6	CAPACITY	capacity	NNP	p2=NN	9	nn	_
7	006	0	CD	_	6	num	_
8	pivotal	pivotal	JJ	_	9	amod	_
9	trial	trial	NN	_	10	nsubj	10:A1=PAG
10	failed	fail	VBD	p2=VBN|pb=fail.01	3	advcl	_
11	may	may	MD	_	13	aux	13:AM-MOD
12	have	have	VB	_	13	aux	_
13	been	be	VBN	pb=be.01	3	ccomp	3:A1=PPT
14	because	because	IN	_	13	prep	13:AM-CAU
15	of	of	IN	_	14	pcomp	_
16	the	the	DT	_	19	det	_
17	higher	high	JJR	_	19	amod	_
18	placebo	placebo	NN	_	19	nn	_
19	response	response	NN	_	14	pobj	_
20	in	in	IN	_	19	prep	_
21	CAPACITY	capacity	NNP	p2=NN	20	pobj	_
22	,	,	,	_	24	punct	_
23	they	they	PRP	_	24	nsubj	24:A0=PAG
24	noted	note	VBD	pb=note.01	0	root	_
25	.	.	.	_	24	punct	_

1	"	"	``	_	7	punct	_
2	In	in	IN	_	7	prep	7:AM-LOC
3	our	our	PRP$	_	4	poss	_
4	study	study	NN	_	2	pobj	_
5	,	,	,	_	7	punct	_
6	we	we	PRP	_	7	nsubj	7:A0=PAG
7	modified	modify	VBD	pb=modify.01	31	ccomp	31:A1=PPT
8	certain	certain	JJ	_	9	amod	_
9	aspects	aspect	NNS	_	7	dobj	7:A1=PPT
10	of	of	IN	_	9	prep	_
11	the	the	DT	_	14	det	_
12	CAPACITY	capacity	NNP	p2=NN	14	nn	_
13	study	study	NN	_	14	nn	_
14	design	design	NN	_	10	pobj	_
15	,	,	,	_	9	punct	_
16	including	include	VBG	_	9	prep	_
17	increasing	increase	VBG	pb=increase.01	16	pcomp	_
18	the	the	DT	_	20	det	_
19	sample	sample	NN	p2=JJ	20	nn	_
20	size	size	NN	_	17	dobj	17:A1=PPT
21	and	and	CC	_	17	cc	_
22	requiring	require	VBG	pb=require.01	17	conj	_
23	central	central	JJ	_	24	amod	_
24	confirmation	confirmation	NN	_	22	dobj	22:A1=PPT
25	of	of	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	diagnosis	diagnosis	NN	_	25	pobj	_
28	,	,	,	_	31	punct	_
29	"	"	''	p2=``	31	punct	_
30	they	they	PRP	_	31	nsubj	31:A0
31	explained	explain	VBD	pb=explain.01	0	root	_
32	.	.	.	_	31	punct	_

1	"	"	``	_	5	punct	_
2	We	we	PRP	p2=NNP	4	nsubj	4:A0=PAG
3	also	also	RB	_	4	advmod	4:AM-DIS
4	modified	modify	VBD	p2=VBN|pb=modify.01	0	root	_
5	selected	select	VBN	p2=VBD|pb=select.01	7	amod	_
6	eligibility	eligibility	NN	p2=JJ	7	nn	_
7	criteria	criterion	NNS	_	4	dobj	4:A1=PPT;5:A1=PPT
8	in	in	IN	_	4	prep	4:AM-PRP
9	order	order	NN	_	8	pobj	_
10	to	to	TO	_	11	aux	_
11	enroll	enroll	VB	pb=enroll.01	9	infmod	_
12	patients	patient	NNS	_	11	dobj	11:A1=PPT
13	at	at	IN	_	11	prep	11:A2=GOL
14	higher	high	JJR	_	15	amod	_
15	risk	risk	NN	_	13	pobj	_
16	for	for	IN	_	15	prep	_
17	disease	disease	NN	p2=JJ	18	nn	_
18	progression	progression	NN	_	16	pobj	_
19	.	.	.	_	4	punct	_
20	"	"	''	_	4	punct	_

1	Still	still	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	there	there	EX	_	4	expl	_
4	was	be	VBD	pb=be.02	0	root	_
5	general	general	JJ	_	6	amod	_
6	similarity	similarity	NN	_	4	attr	4:A1=PPT
7	in	in	IN	_	6	prep	_
8	1	0	CD	_	9	num	_
9	year	year	NN	_	10	nn	_
10	results	result	NNS	_	7	pobj	_
11	compared	compare	VBN	_	4	prep	4:AM-ADV
12	with	with	IN	_	11	prep	_
13	the	the	DT	_	16	det	_
14	pivotal	pivotal	JJ	_	15	amod	_
15	trials	trial	NNS	_	16	nn	_
16	studies	study	NNS	_	12	pobj	_
17	without	without	IN	_	16	prep	_
18	central	central	JJ	_	20	amod	_
19	diagnosis	diagnosis	NN	_	20	nn	_
20	confirmation	confirmation	NN	_	17	pobj	_
21	,	,	,	_	20	punct	_
22	which	which	WDT	_	26	nsubj	_
23	they	they	PRP	_	24	nsubj	24:A0
24	said	say	VBD	pb=say.01	16	rcmod	_
25	"	"	``	_	24	punct	_
26	militates	militates	NNS	p2=VBZ	24	ccomp	24:A1=PPT
27	against	against	IN	_	26	prep	_
28	any	any	DT	_	29	det	_
29	limitation	limitation	NN	_	27	pobj	34:A1=PPT
30	that	that	IN	p2=WDT	34	complm	_
31	this	this	DT	_	32	det	_
32	requirement	requirement	NN	_	34	nsubj	34:A0=PAG
33	might	might	MD	_	34	aux	34:AM-MOD
34	impose	impose	VB	pb=impose.01	29	rcmod	_
35	on	on	IN	_	34	prep	34:A2=GOL
36	the	the	DT	_	37	det	_
37	generalizability	generalizability	NN	_	35	pobj	_
38	of	of	IN	_	37	prep	_
39	our	our	PRP$	_	40	poss	_
40	results	result	NNS	_	38	pobj	_
41	.	.	.	_	4	punct	_
42	"	"	''	_	4	punct	_

1	The	the	DT	_	3	det	_
2	study	study	NN	p2=JJ	3	nn	_
3	population	population	NN	_	5	nsubj	5:A0
4	had	have	VBD	_	5	aux	_
5	mild	mild	VBN	p2=NN|pb=mild.01	32	ccomp	_
6	-	-	HYPH	_	9	hyph	_
7	to	to	IN	p2=TO	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	moderate	moderate	JJ	p2=NN	11	amod	_
10	physiological	physiological	NN	p2=JJ	11	nn	_
11	impairment	impairment	NN	_	5	dobj	5:A1
12	,	,	,	_	32	punct	_
13	so	so	IN	p2=RB	15	mark	_
14	it	it	PRP	_	15	nsubj	_
15	's	be	VBZ	pb=be.01	32	advcl	32:AM-CAU
16	not	not	RB	_	15	neg	15:AM-NEG
17	clear	clear	JJ	_	15	acomp	15:A2=PRD
18	how	how	WRB	_	19	advmod	_
19	well	well	RB	_	23	advmod	23:R-AM-MNR
20	the	the	DT	_	21	det	_
21	results	result	NNS	p2=NN	23	nsubj	23:A0=PAG
22	would	would	MD	_	23	aux	23:AM-MOD
23	generalize	generalize	VB	pb=generalize.01	15	ccomp	15:A1=PPT
24	to	to	IN	_	23	prep	23:A1=PPT
25	patients	patient	NNS	_	24	pobj	_
26	with	with	IN	_	25	prep	_
27	advanced	advanced	JJ	_	28	amod	_
28	disease	disease	NN	_	26	pobj	_
29	,	,	,	_	32	punct	_
30	the	the	DT	_	31	det	_
31	group	group	NN	_	32	nsubj	32:A0=PAG
32	cautioned	caution	VBD	pb=caution.01	0	root	_
33	.	.	.	_	32	punct	_

1	"	"	``	_	18	punct	_
2	Although	although	IN	_	5	mark	_
3	these	these	DT	_	4	det	_
4	results	result	NNS	_	5	nsubj	5:A1=PPT
5	are	be	VBP	pb=be.01	18	advcl	18:AM-ADV
6	a	a	DT	_	8	det	_
7	major	major	JJ	_	8	amod	_
8	breakthrough	breakthrough	NN	_	5	attr	5:A2=PRD
9	for	for	IN	_	8	prep	_
10	patients	patient	NNS	_	9	pobj	_
11	with	with	IN	_	10	prep	_
12	idiopathic	idiopathic	JJ	_	14	amod	_
13	pulmonary	pulmonary	JJ	_	14	amod	_
14	fibrosis	fibrosis	NN	_	11	pobj	_
15	,	,	,	_	18	punct	_
16	we	we	PRP	_	18	nsubj	21:A0=PAG;18:A1=PPT
17	should	should	MD	_	18	aux	18:AM-MOD
18	be	be	VB	pb=be.01	0	root	_
19	cautious	cautious	JJ	_	18	acomp	18:A2=PRD
20	in	in	IN	_	19	prep	_
21	extrapolating	extrapolate	VBG	pb=extrapolate.01	20	pcomp	_
22	these	these	DT	_	23	det	_
23	findings	finding	NNS	_	21	dobj	21:A1=PPT
24	to	to	IN	_	21	prep	21:A2=PPT
25	patients	patient	NNS	_	24	pobj	27:A1=PPT
26	who	who	WP	_	27	nsubj	27:R-A1
27	fall	fall	VBP	pb=fall.01	25	rcmod	_
28	outside	outside	IN	_	27	prep	27:A4=GOL
29	the	the	DT	_	31	det	_
30	recruitment	recruitment	NN	_	31	nn	_
31	criteria	criterion	NNS	_	28	pobj	_
32	for	for	IN	_	31	prep	_
33	these	these	DT	_	34	det	_
34	trials	trial	NNS	_	32	pobj	_
35	,	,	,	_	38	punct	_
36	"	"	''	p2=``	38	punct	_
37	Hunninghake	hunninghake	NNP	p2=NN	38	nsubj	38:A0=PAG;41:A0=PAG
38	added	add	VBD	pb=add.01	0	root	_
39	,	,	,	_	38	punct	_
40	in	in	IN	_	38	prep	38:AM-MNR
41	referencing	reference	VBG	pb=reference.01	40	pcomp	_
42	the	the	DT	_	43	det	_
43	group	group	NN	_	41	dobj	41:A1=PPT;46:A1
44	of	of	IN	_	43	prep	_
45	trials	trial	NNS	_	44	pobj	_
46	reported	report	VBN	p2=VBD|pb=report.01	43	partmod	_
47	together	together	RB	_	46	advmod	46:AM-MNR
48	here	here	RB	_	46	advmod	46:AM-LOC
49	.	.	.	_	18	punct	_

1	The	the	DT	_	2	det	_
2	trial	trial	NN	_	4	nsubjpass	4:A1=PPT
3	was	be	VBD	_	4	auxpass	_
4	funded	fund	VBN	pb=fund.01	0	root	_
5	by	by	IN	_	4	agent	4:A0=PAG
6	InterMune	intermune	NNP	_	5	pobj	_
7	.	.	.	_	4	punct	_

1	King	king	NNP	p2=VBG	2	nsubj	2:A0
2	disclosed	disclose	VBD	pb=disclose.01	0	root	_
3	relationships	relationship	NNS	_	2	dobj	2:A1=PPT
4	with	with	IN	_	3	prep	_
5	InterMune	intermune	NNP	_	4	pobj	_
6	,	,	,	_	5	punct	_
7	Immune	immune	NNP	_	8	nn	_
8	Works	works	NNP	p2=NNPS	5	conj	_
9	,	,	,	_	8	punct	_
10	Daiichi	daiichi	NNP	_	11	nn	_
11	Sankyo	sankyo	NNP	_	8	conj	_
12	,	,	,	_	11	punct	_
13	Boehringer	boehringer	NNP	_	14	nn	_
14	Ingelheim	ingelheim	NNP	_	11	conj	_
15	,	,	,	_	14	punct	_
16	and	and	CC	_	14	cc	_
17	the	the	DT	_	18	det	_
18	NIH	nih	NNP	_	14	conj	_
19	.	.	.	_	2	punct	_

1	Hunninghake	hunninghake	NNP	p2=NN	2	nsubj	2:A0
2	disclosed	disclose	VBD	pb=disclose.01	0	root	_
3	no	no	DT	p2=UH	5	det	_
4	relevant	relevant	JJ	_	5	amod	_
5	relationships	relationship	NNS	_	2	dobj	2:A1=PPT
6	with	with	IN	_	5	prep	_
7	industry	industry	NN	_	6	pobj	_
8	.	.	.	_	2	punct	_

1	This	this	DT	_	2	det	_
2	survey	survey	NN	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	a	a	DT	_	5	det	_
5	poll	poll	NN	_	3	attr	3:A2=PRD
6	of	of	IN	_	5	prep	_
7	those	those	DT	_	6	pobj	9:A0=PAG;11:A0=PAG;13:A1=PPT
8	who	who	WP	_	9	nsubj	9:R-A0;11:R-A0;13:R-A1
9	choose	choose	VBP	pb=choose.01	7	rcmod	_
10	to	to	TO	_	11	aux	_
11	participate	participate	VB	pb=participate.01	9	xcomp	9:A1=PPT
12	and	and	CC	_	9	cc	_
13	are	be	VBP	p2=VB|pb=be.01	9	conj	_
14	,	,	,	_	13	punct	_
15	therefore	therefore	RB	_	20	advmod	_
16	,	,	,	_	20	punct	_
17	not	not	RB	_	18	neg	_
18	valid	valid	JJ	_	20	amod	_
19	statistical	statistical	JJ	_	20	amod	_
20	samples	sample	NNS	_	13	attr	13:A2=PRD
21	,	,	,	_	20	punct	_
22	but	but	CC	_	20	cc	_
23	rather	rather	RB	_	22	advmod	_
24	a	a	DT	_	25	det	_
25	snapshot	snapshot	NN	_	3	conj	_
26	of	of	IN	_	25	prep	_
27	what	what	WP	_	31	dobj	31:R-A1
28	your	your	PRP$	_	29	poss	_
29	colleagues	colleague	NNS	_	31	nsubj	31:A0
30	are	be	VBP	_	31	aux	_
31	thinking	think	VBG	p2=JJ|pb=think.01	26	pcomp	_
32	.	.	.	_	3	punct	_

1	MedPageToday	medpagetoday	NNP	p2=NN	0	root	3:A1=GOL
2	,	,	,	_	1	punct	_
3	powered	power	VBN	pb=power.01	1	partmod	_
4	by	by	IN	_	3	agent	3:A0=PAG
5	Everyday	everyday	NNP	_	7	nn	_
6	Health	health	NNP	_	7	nn	_
7	Inc	inc	NNP	_	4	pobj	_
8	.	.	.	_	1	punct	_

1	,	,	,	_	2	punct	_
2	is	be	VBZ	pb=be.01	0	root	_
3	a	a	DT	_	7	det	_
4	trusted	trusted	JJ	_	7	amod	_
5	and	and	CC	_	4	cc	_
6	reliable	reliable	JJ	_	4	conj	_
7	source	source	NN	_	2	attr	2:A2=PRD
8	for	for	IN	_	7	prep	_
9	clinical	clinical	JJ	_	12	amod	_
10	and	and	CC	_	9	cc	_
11	policy	policy	NN	_	9	conj	_
12	coverage	coverage	NN	_	8	pobj	15:A0=PAG
13	that	that	WDT	_	15	nsubj	15:R-A0
14	directly	directly	RB	_	15	advmod	15:AM-MNR
15	affects	affect	VBZ	pb=affect.01	12	rcmod	_
16	the	the	DT	_	17	det	_
17	lives	life	NNS	_	15	dobj	15:A1=PPT
18	and	and	CC	_	17	cc	_
19	practices	practice	NNS	_	17	conj	_
20	of	of	IN	_	19	prep	_
21	health	health	NN	_	22	nn	_
22	care	care	NN	_	23	nn	_
23	professionals	professional	NNS	_	20	pobj	_
24	.	.	.	_	2	punct	_

1	Physicians	physicians	NNP	p2=NNPS	8	nsubj	8:A0=PAG
2	and	and	CC	_	1	cc	_
3	other	other	JJ	_	5	amod	_
4	healthcare	healthcare	NN	_	5	nn	_
5	professionals	professional	NNS	_	1	conj	_
6	may	may	MD	_	8	aux	8:AM-MOD
7	also	also	RB	_	8	advmod	8:AM-DIS
8	receive	receive	VB	pb=receive.01	0	root	_
9	Continuing	continuing	NNP	_	11	nn	_
10	Medical	medical	NNP	_	11	nn	_
11	Education	education	NNP	_	8	dobj	8:A1=PPT
12	(	(	-LRB-	_	11	punct	_
13	CME	cme	NNP	_	11	appos	_
14	)	)	-RRB-	_	11	punct	_
15	and	and	CC	_	11	cc	_
16	Continuing	continuing	NNP	_	17	nn	_
17	Education	education	NNP	_	11	conj	_
18	(	(	-LRB-	_	19	punct	_
19	CE	ce	NNP	_	17	appos	_
20	)	)	-RRB-	_	19	punct	_
21	credits	credit	VBZ	p2=NNS	8	dobj	_
22	at	at	IN	_	8	prep	8:AM-MNR
23	no	no	DT	_	24	det	_
24	cost	cost	NN	_	22	pobj	_
25	for	for	IN	_	24	prep	_
26	participating	participate	VBG	pb=participate.01	25	pcomp	_
27	in	in	IN	p2=RP	26	prep	26:A1=PPT
28	MedPage	medpage	NNP	_	29	nn	_
29	Today	today	NNP	p2=NN	31	hmod	_
30	-	-	HYPH	p2=:	31	hyph	_
31	hosted	host	VBN	p2=VBD	33	amod	_
32	educational	educational	JJ	_	33	amod	_
33	activities	activity	NNS	_	27	pobj	_
34	.	.	.	_	8	punct	_

1	©	©	SYM	p2=IN	4	punct	_
2	2014	0	CD	_	4	num	_
3	MedPage	medpage	NNP	p2=NN	4	nn	_
4	Today	today	NN	p2=NNP	0	root	_
5	,	,	,	_	4	punct	_
6	LLC	llc	NNP	_	4	appos	_
7	.	.	.	_	3	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Use	use	NN	p2=VB	5	nsubj	5:A0=PAG
2	of	of	IN	_	1	prep	_
3	this	this	DT	_	4	det	_
4	site	site	NN	_	2	pobj	_
5	constitutes	constitute	VBZ	pb=constitute.01	0	root	_
6	acceptance	acceptance	NN	_	5	dobj	5:A1=PPT
7	of	of	IN	_	6	prep	_
8	the	the	DT	_	10	det	_
9	MedPageToday.com	#url#	ADD	_	10	amod	_
10	terms	term	NNS	_	7	pobj	_
11	of	of	IN	_	10	prep	_
12	use	use	NN	_	11	pobj	_
13	and	and	CC	_	12	cc	_
14	privacy	privacy	NN	_	15	nn	_
15	policy	policy	NN	_	12	conj	_
16	.	.	.	_	5	punct	_

1	The	the	DT	_	2	det	_
2	material	material	NN	_	6	nsubj	6:A1=PPT;13:A1=PPT
3	on	on	IN	_	2	prep	_
4	this	this	DT	_	5	det	_
5	site	site	NN	_	3	pobj	_
6	is	be	VBZ	pb=be.01	0	root	_
7	for	for	IN	_	6	prep	6:A2=PRD
8	informational	informational	JJ	_	9	amod	_
9	purposes	purpose	NNS	_	7	pobj	_
10	only	only	RB	_	9	advmod	_
11	,	,	,	_	6	punct	_
12	and	and	CC	_	6	cc	_
13	is	be	VBZ	pb=be.01	6	conj	_
14	not	not	RB	_	13	neg	13:AM-NEG
15	a	a	DT	_	16	det	_
16	substitute	substitute	NN	_	13	attr	13:A2=PRD
17	for	for	IN	_	16	prep	_
18	medical	medical	JJ	_	19	amod	_
19	advice	advice	NN	_	17	pobj	24:A1
20	,	,	,	_	19	punct	_
21	diagnosis	diagnosis	NN	_	24	nsubj	_
22	or	or	CC	_	21	cc	_
23	treatment	treatment	NN	_	21	conj	_
24	provided	provided	VBN	pb=provide.01	19	partmod	_
25	by	by	IN	_	24	agent	24:A0
26	a	a	DT	_	30	det	_
27	qualified	qualified	JJ	_	30	amod	_
28	health	health	NN	_	29	nn	_
29	care	care	NN	_	30	nn	_
30	provider	provider	NN	_	25	pobj	_
31	.	.	.	_	6	punct	_

